1Avis NE, et al. "Duration of Menopausal Vasomotor Symptoms Over the Menopause Transition." JAMA Internal Medicine. 2015;175(4):531–539.
2Freedman RR. "Pathophysiology and treatment of menopausal hot flashes." Seminars in Reproductive Medicine. 2005;23(2):117–125.
3Rance NE, et al. "Modulation of body temperature and LH secretion by hypothalamic KNDy (kisspeptin, neurokinin B and dynorphin) neurons." Peptides. 2010;31(12):2233–2238.
4Whiteman MK, et al. "Smoking, body mass, and hot flashes in midlife women." Obstetrics & Gynecology. 2003;101(2):264–272.
5MacLennan AH, et al. "Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes." Cochrane Database of Systematic Reviews. 2004;(4):CD002978.
6The 2023 Menopause Society Position Statement. "The 2023 nonhormone therapy position statement of The Menopause Society." Menopause. 2023;30(6):573–590.
7Kravitz HM, et al. "Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition." Menopause. 2003;10(1):19–28.
8Gold EB, et al. "Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40–55 years of age." American Journal of Epidemiology. 2000;152(5):463–473.
9Lederman S, et al. "Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study." The Lancet. 2023;401(10382):1091–1102.
10Ayers B, et al. "The impact of cognitive behavioural therapy on hot flushes and night sweats: a randomised controlled trial." Menopause. 2012;19(7):749–759.